BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010; 1(3): 97-105 [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Moloney RD, Johnson AC, O’Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neurosci Ther. 2016;22:102-117. [PMID: 26662472 DOI: 10.1111/cns.12490] [Cited by in Crossref: 143] [Cited by in F6Publishing: 120] [Article Influence: 23.8] [Reference Citation Analysis]
2 Salari-Moghaddam A, Keshteli AH, Esmaillzadeh A, Adibi P. Empirically derived food-based inflammatory potential of the diet, irritable bowel syndrome, and its severity. Nutrition 2019;63-64:141-7. [PMID: 31029043 DOI: 10.1016/j.nut.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Fehér J, Kovács I, Pacella E, Radák Z. [Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind syndrome]. Orv Hetil 2014;155:1454-60. [PMID: 25194867 DOI: 10.1556/OH.2014.29987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Xiao HT, Zhong L, Tsang SW, Lin ZS, Bian ZX. Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings. Am J Chin Med 2015;43:1-23. [PMID: 25579759 DOI: 10.1142/S0192415X15500019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
5 Fukudo S, Kuwano H, Miwa H. Management and pathophysiology of functional gastrointestinal disorders. Digestion. 2012;85:85-89. [PMID: 22269284 DOI: 10.1159/000334652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Olsen AB, Hetz RA, Xue H, Aroom KR, Bhattarai D, Johnson E, Bedi S, Cox CS Jr, Uray K. Effects of traumatic brain injury on intestinal contractility. Neurogastroenterol Motil 2013;25:593-e463. [PMID: 23551971 DOI: 10.1111/nmo.12121] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
7 Chen B, Zhu S, Du L, He H, Kim JJ, Dai N. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model. Scand J Gastroenterol. 2017;52:1065-1071. [PMID: 28679338 DOI: 10.1080/00365521.2017.1342141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li Y, Yang T, Yao Q, Li S, Fang E, Li Y, Liu C, Li W. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like rats. Neurogastroenterology & Motility 2019;31:e13556. [DOI: 10.1111/nmo.13556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest. 2015;45:1350-1359. [PMID: 26444549 DOI: 10.1111/eci.12548] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
10 Singh M, Singh V, Schurman JV, Colombo JM, Friesen CA. The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Sci Rep 2020;10:11988. [PMID: 32686762 DOI: 10.1038/s41598-020-68961-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Chu H, Fox M, Zheng X, Deng Y, Long Y, Huang Z, Du L, Xu F, Dai N. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract. 2016;2016:3230859. [PMID: 27379166 DOI: 10.1155/2016/3230859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
12 Saps M, Adams P, Bonilla S, Nichols-vinueza D. Abdominal Pain and Functional Gastrointestinal Disorders in Children with Celiac Disease. The Journal of Pediatrics 2013;162:505-9. [DOI: 10.1016/j.jpeds.2012.08.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zeng L, Li K, Wei H, Hu J, Jiao L, Yu S, Xiong Y. A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways. Front Pharmacol 2018;9:272. [PMID: 29662452 DOI: 10.3389/fphar.2018.00272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, Xie P, Morrison M, Wesselingh SL, Rogers GB, Licinio J. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry 2016;21:797-805. [PMID: 27090302 DOI: 10.1038/mp.2016.46] [Cited by in Crossref: 232] [Cited by in F6Publishing: 202] [Article Influence: 46.4] [Reference Citation Analysis]
15 Borbély YM, Osterwalder A, Kröll D, Nett PC, Inglin RA. Diarrhea after bariatric procedures: Diagnosis and therapy. World J Gastroenterol 2017;23:4689-700. [PMID: 28765690 DOI: 10.3748/wjg.v23.i26.4689] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
16 Lee SH, Athavankar S, Cohen T, Piran R, Kiselyuk A, Levine F. Identification of alverine and benfluorex as HNF4α activators. ACS Chem Biol 2013;8:1730-6. [PMID: 23675775 DOI: 10.1021/cb4000986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Hilmi I, Hartono JL, Pailoor J, Mahadeva S, Goh KL. Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea. BMC Gastroenterol 2013;13:80. [PMID: 23651739 DOI: 10.1186/1471-230X-13-80] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
18 Akiho H, Ihara E, Motomura Y, Nakamura K. Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol. 2011;2:72-81. [PMID: 22013552 DOI: 10.4291/wjgp.v2.i5.72] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
19 Moloney RD, O'Mahony SM, Dinan TG, Cryan JF. Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry 2015;6:15. [PMID: 25762939 DOI: 10.3389/fpsyt.2015.00015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 14.3] [Reference Citation Analysis]
20 Theofanous SA, Florens MV, Appeltans I, Denadai Souza A, Wood JN, Wouters MM, Boeckxstaens GE. Ephrin-B2 signaling in the spinal cord as a player in post-inflammatory and stress-induced visceral hypersensitivity. Neurogastroenterol Motil 2020;32:e13782. [PMID: 32004400 DOI: 10.1111/nmo.13782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lee CG, Lee JK, Kang YS, Shin S, Kim JH, Lim YJ, Koh MS, Lee JH, Kang HW. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome. Am J Gastroenterol. 2015;110:310-319. [PMID: 25583325 DOI: 10.1038/ajg.2014.422] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
22 Rana SV, Sharma S, Kaur J, Prasad KK, Sinha SK, Kochhar R, Malik A, Morya RK. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohns Colitis. 2014;8:859-865. [PMID: 24456736 DOI: 10.1016/j.crohns.2014.01.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
23 Farmer AD, Wood E, Ruffle JK. An approach to the care of patients with irritable bowel syndrome. CMAJ 2020;192:E275-82. [PMID: 32179536 DOI: 10.1503/cmaj.190716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Alt F, Chong PW, Teng E, Uebelhack R. Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial. Phytother Res 2017;31:1056-62. [PMID: 28508427 DOI: 10.1002/ptr.5826] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Kanauchi O, Andoh A, Mitsuyama K. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function. J Agric Food Chem. 2013;61:9977-9983. [PMID: 24070265 DOI: 10.1021/jf402441f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
26 Lee EH, Yang HR, Lee HS. Quantitative Analysis of Distribution of the Gastrointestinal Tract Eosinophils in Childhood Functional Abdominal Pain Disorders. J Neurogastroenterol Motil 2018;24:614-27. [PMID: 30180307 DOI: 10.5056/jnm18050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 2014;20:384-400. [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 54] [Article Influence: 9.1] [Reference Citation Analysis]
28 Romero-valdovinos M, Gudiño-ramírez A, Reyes-gordillo J, Martínez-flores WA, Ramírez-miranda ME, Maravilla P, Olivo-díaz A. Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Mol Biol Rep 2012;39:8837-43. [DOI: 10.1007/s11033-012-1745-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
29 Mitselou A, Grammeniatis V, Varouktsi A, Papadatos SS, Katsanos K, Galani V. Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease. Intest Res 2020;18:115-20. [PMID: 32013318 DOI: 10.5217/ir.2019.00125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
30 Asproudis I, Tsoumani AT, Katsanos KH, Katsanos AH, Theopistos V, Paschidis KA, Tsianos EV, Christodoulou D. Irritable bowel syndrome might be associated with dry eye disease. Ann Gastroenterol 2016;29:487-91. [PMID: 27708515 DOI: 10.20524/aog.2016.0064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Barbalho SM, Goulart RA, Araújo AC, Guiguer ÉL, Bechara MD. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol 2019;13:345-59. [PMID: 30791775 DOI: 10.1080/17474124.2019.1570137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
32 Salari-Moghaddam A, Keshteli AH, Esmaillzadeh A, Adibi P. Adherence to the pro-inflammatory diet in relation to prevalence of irritable bowel syndrome. Nutr J 2019;18:72. [PMID: 31711479 DOI: 10.1186/s12937-019-0487-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
33 Lichtenberger LM, Bhattarai D, Phan TM, Dial EJ, Uray K. Suppression of contractile activity in the small intestine by indomethacin and omeprazole. Am J Physiol Gastrointest Liver Physiol 2015;308:G785-93. [PMID: 25721304 DOI: 10.1152/ajpgi.00458.2014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
34 Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012;107:657-66; quiz 667. [PMID: 22488077 DOI: 10.1038/ajg.2012.49] [Cited by in Crossref: 123] [Cited by in F6Publishing: 93] [Article Influence: 13.7] [Reference Citation Analysis]
35 Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract 2021;15:411-30. [PMID: 34349876 DOI: 10.4162/nrp.2021.15.4.411] [Reference Citation Analysis]
36 Lin YM, Li F, Shi XZ. Mechanical stress is a pro-inflammatory stimulus in the gut: in vitro, in vivo and ex vivo evidence. PLoS One 2014;9:e106242. [PMID: 25180799 DOI: 10.1371/journal.pone.0106242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
37 la Roca-Chiapas JM, Cordova-Fraga T. Biomagnetic techniques for evaluating gastric emptying, peristaltic contraction and transit time. World J Gastrointest Pathophysiol 2011;2:65-71. [PMID: 22025978 DOI: 10.4291/wjgp.v2.i5.65] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 2015;15:67. [PMID: 25888448 DOI: 10.1186/s12866-015-0400-1] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 18.2] [Reference Citation Analysis]
39 Van Vleck Pereira R, Lima S, Siler JD, Foditsch C, Warnick LD, Bicalho RC. Ingestion of Milk Containing Very Low Concentration of Antimicrobials: Longitudinal Effect on Fecal Microbiota Composition in Preweaned Calves. PLoS One 2016;11:e0147525. [PMID: 26808865 DOI: 10.1371/journal.pone.0147525] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
40 Pesce M, D'Alessandro A, Borrelli O, Gigli S, Seguella L, Cuomo R, Esposito G, Sarnelli G. Endocannabinoid-related compounds in gastrointestinal diseases. J Cell Mol Med. 2018;22:706-715. [PMID: 28990365 DOI: 10.1111/jcmm.13359] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
41 Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother. 2014;10:1611-1621. [PMID: 24732667 DOI: 10.4161/hv.28549] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
42 El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med 2014;34:363-71. [PMID: 24939595 DOI: 10.3892/ijmm.2014.1811] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
43 Orlando A, Tutino V, Notarnicola M, Riezzo G, Linsalata M, Clemente C, Prospero L, Martulli M, D'Attoma B, De Nunzio V, Russo F. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective. Nutrients 2020;12:E1652. [PMID: 32498383 DOI: 10.3390/nu12061652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol. 2014;8:435-443. [PMID: 24580043 DOI: 10.1586/17474124.2014.888952] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
45 Yang B, Zhou X, Lan C. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome. BMC Gastroenterol. 2015;15:43. [PMID: 25886744 DOI: 10.1186/s12876-015-0272-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
46 Fritscher-ravens A, Milla P, Ellrichmann M, Hellwig I, Böttner M, Hadeler K, Wedel T. A novel endoscopic prototype device for gastric full-thickness biopsy for the histopathologic diagnosis of GI neuromuscular pathology: in vivo porcine long-term survival study (with videos). Gastrointestinal Endoscopy 2013;77:262-71. [DOI: 10.1016/j.gie.2012.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Balmus IM, Cojocariu RO, Ciobica A, Strungaru S, Strungaru-Jijie R, Cantemir A, Galatanu C, Gorgan L. Preliminary Study on the Tears Oxidative Stress Status and Sleep Disturbances in Irritable Bowel Syndrome Patients. Oxid Med Cell Longev 2020;2020:4690713. [PMID: 32566082 DOI: 10.1155/2020/4690713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Yang J, Shang B, Shi H, Zhu S, Lu G, Dai F. The role of toll-like receptor 4 and mast cell in the ameliorating effect of electroacupuncture on visceral hypersensitivity in rats. Neurogastroenterol Motil 2019;31:e13583. [PMID: 30916854 DOI: 10.1111/nmo.13583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
49 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126-14131. [PMID: 25339801 DOI: 10.3748/wjg.v20.i39.14126] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 79] [Article Influence: 15.8] [Reference Citation Analysis]
50 Lind R, Berstad A, Hatlebakk J, Valeur J. Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact Scale. Clin Exp Gastroenterol. 2013;6:101-107. [PMID: 23869173 DOI: 10.2147/ceg.s45760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
51 Sikora M, Stec A, Chrabaszcz M, Giebultowicz J, Samborowska E, Jazwiec R, Dadlez M, Olszewska M, Rudnicka L. Clinical Implications of Intestinal Barrier Damage in Psoriasis. J Inflamm Res 2021;14:237-43. [PMID: 33542642 DOI: 10.2147/JIR.S292544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Tsang SW, Auyeung KK, Bian ZX, Ko JK. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis. Curr Neuropharmacol. 2016;14:842-856. [PMID: 27009115 DOI: 10.2174/1570159x14666160324144154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
53 Kisla Ekinci RM, Balcı S, Mart OO, Tumgor G, Yavuz S, Celik H, Dogruel D, Altintas DU, Yilmaz M. Is Henoch–Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children? Rheumatol Int 2019;39:317-22. [DOI: 10.1007/s00296-018-4129-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]